10
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Challenges in determining the benefits of restaging after chemoradiotherapy for locally advanced rectal cancer

, , &
Pages 121-125 | Published online: 16 May 2014

References

  • Merkel S , MansmannU, SiassiM, PapadopoulosT, HohenbergerW, HermanekP. The prognostic inhomogeneity in pT3 rectal carcinomas. Int. J. Colorectal Dis.16(5), 298–304 (2001).
  • Nagtegaal ID , QuirkeP. What is the role for the circumferential margin in the modern treatment of rectal cancer?J. Clin. Oncol.26(2), 303–312 (2008).
  • Secco GB , RaveraG, BonfantePet al. Prognostic indicators of local recurrence in patients operated for rectal cancer. Hepatogastroenterology48(41), 1346–1350 (2001).
  • Talbot IC , RitchieS, LeightonMH, HughesAO, BusseyHJ, MorsonBC. The clinical significance of invasion of veins by rectal cancer. Br. J. Surg.67(6), 439–442 (1980).
  • Bosset JF , ColletteL, CalaisGet al. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med.355(11), 1114–1123 (2006).
  • Gerard JP , ConroyT, BonnetainFet al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J. Clin. Oncol.24(28), 4620–4625 (2006).
  • Verhoef C , de WiltJH, BurgerJW, VerheulHM, KoopmanM. Surgery of the primary in stage IV colorectal cancer with unresectable metastases. Eur. J. Cancer47(Suppl. 3), S61–S66 (2011).
  • Beets-Tan RG , BeetsGL, BorstlapACet al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom. Imaging25(5), 533–541 (2000).
  • Blomqvist L , HolmT, NyrenS, SvanstromR, UlvskogY, IseliusL. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin. Radiol.57(3), 211–218 (2002).
  • Mathur P , SmithJJ, RamseyCet al. Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis.5(5), 396–401 (2003).
  • MERCURY Study Group . Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333(7572), 779 (2006).
  • Engstrom PF , ArnolettiJP, BensonAB3rdet al. NCCN clinical practice guidelines in oncology: rectal cancer. J. Natl Compr. Canc. Netw.7(8), 838–881 (2009).
  • Oncoline. Dutch guideline for rectal cancer. www.oncoline.nl/rectumcarcinoom
  • Schmoll HJ , Van CutsemE, SteinAet al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann. Oncol.23(10), 2479–2516 (2012).
  • Lim SB , ChoiHS, JeongSYet al. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann. Surg.248(2), 243–251 (2008).
  • Theodoropoulos G , WiseWE, PadmanabhanAet al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis. Colon Rectum45(7), 895–903 (2002).
  • Wheeler JM , DoddsE, WarrenBFet al. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis. Colon Rectum47(12), 2025–2031 (2004).
  • Beets-Tan RG , LambregtsDM, MaasMet al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol.23(9), 2522–2531 (2013).
  • van der Paardt MP , ZagersMB, Beets-TanRG, StokerJ, BipatS. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology269(1), 101–112 (2013).
  • Alberda WJ , DassenHP, DwarkasingRSet al. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis.28(4), 573–580 (2013).
  • Hanly AM , RyanEM, RogersACet al. Multicenter evaluation of rectal cancer reimaging post neoadjuvant (MERRION) therapy. Ann. Surg. 259 (4), 723–727 (2014).
  • Gerard A , BuyseM, NordlingerBet al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann. Surg.208(5), 606–614 (1988).
  • Aschele C , CioniniL, LonardiSet al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized Phase III trial. J. Clin. Oncol.29(20), 2773–2780 (2011).
  • Gerard JP , RostomY, GalJet al. Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. Crit. Rev. Oncol. Hematol.81(1), 21–28 (2012).
  • Barbaro B , FiorucciC, TebalaCet al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology250(3), 730–739 (2009).
  • Suppiah A , HunterIA, CowleyJet al. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis.11(3), 249–253 (2009).
  • Habr-Gama A , PerezRO, NadalinWet al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann. Surg.240(4), 711–717; discussion 717–718 (2004).
  • Maas M , Beets-TanRG, LambregtsDMet al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J. Clin. Oncol.29(35), 4633–4640 (2011).
  • Glynne-Jones R , HughesR. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br. J. Surg.99(7), 897–909 (2012).
  • Bokkerink GM , de GraafEJ, PuntCJet al. The CARTS study: chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery. BMC Surg.11, 34 (2011).
  • Beyond TME Collaborative . Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br. J. Surg.100(8), E1–E33 (2013).
  • Patel UB , TaylorF, BlomqvistLet al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J. Clin. Oncol.29(28), 3753–3760 (2011).
  • Dresen RC , BeetsGL, RuttenHJet al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252(1), 71–80 (2009).
  • Patel UB , BrownG, RuttenHet al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann. Surg. Oncol.19(9), 2842–2852 (2012).
  • Sassen S , de BooijM, SosefMet al. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 23(12), 3440–3449 (2013).
  • de Campos-Lobato LF , GeislerDP, da Luz MoreiraA, StocchiL, DietzD, KaladyMF. Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J. Gastrointest. Surg.15(3), 444–450 (2011).
  • Wolthuis AM , PenninckxF, HaustermansKet al. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann. Surg. Oncol.19(9), 2833–2841 (2012).
  • Ayez N , AlberdaWJ, BurgerJWet al. Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary? Ann. Surg. Oncol. 20(1), 155–160 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.